About the Post-Conference Report
- There were 61 TPD abstracts presented at AACR. 51 were preclinical, including data for bivalent degraders, molecular glues and E3 modulators.
- This post-conference report lists abstracts grouped by preclinical and clinical data. Hyperlinks have been provided for the original abstract and the relevant Beacon pages.
Find out more
This insight and data is part of the subscription to Beacon TPD.
Speak with our Team
Our dedicated Sales and Research teams can help you with questions by showing you how this insight and data is collated on Beacon
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements